Cargando…
Treatment and Prognosis of Patients with Lung Cancer and Combined Interstitial Lung Disease
SIMPLE SUMMARY: Interstitial lung disease (ILD) is associated with a higher risk of lung cancer. The impact of underlying ILD on cancer’s clinical characteristics, treatment strategies, and outcome is unclear, particularly in Caucasian populations. In this article, we reviewed the files of all patie...
Autores principales: | Mauclet, Charlotte, Dupont, Michaël V., Roelandt, Kerwin, Regnier, Maxime, Delos, Monique, Pirard, Lionel, Vander Borght, Thierry, Dahlqvist, Caroline, Froidure, Antoine, Rondelet, Benoît, Vanderick, Jean, Remouchamps, Vincent, Duplaquet, Fabrice, Ocak, Sebahat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417812/ https://www.ncbi.nlm.nih.gov/pubmed/37568692 http://dx.doi.org/10.3390/cancers15153876 |
Ejemplares similares
-
Systemic Inflammation/Nutritional Status Scores Are Prognostic but Not Predictive in Metastatic Non-Small-Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors
por: Mahiat, Cédric, et al.
Publicado: (2023) -
Case report: BRAF A598-T599insV mutation as a potential resistance mechanism to alectinib in ALK-rearranged lung adenocarcinoma
por: Pasau, Thomas, et al.
Publicado: (2022) -
Long-term complete remission after severe pembrolizumab-induced immune-related encephalitis in metastatic lung adeno-squamous carcinoma: A case report
por: Quirynen, Rémy, et al.
Publicado: (2023) -
Good Tolerance to Full-Dose Crizotinib in a Patient with Anaplastic Lymphoma Receptor Tyrosine Kinase-Rearranged Lung Adenocarcinoma and Preexisting Renal Impairment
por: Rosoux, Adeline, et al.
Publicado: (2017) -
Restin protein expression in non‐small cell lung cancer
por: Nana, Frank Aboubakar, et al.
Publicado: (2023)